THERAGEN ETEX CO LTD

Featured products of Theragen Etex

Ibandren

Ibandren FC tab 150 mg

ibandronic acid

Packing/Price

1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BA06 - ibandronic acid : Belongs to the class of bisphosphonates. Used in the treatment of bone diseases.

RiteMED Rosuvastatin

RiteMED Rosuvastatin FC tab 10 mg

rosuvastatin calcium

Packing/Price

30's (P832.50/box, P27.75/film-coated tab)

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AA07 - rosuvastatin : Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.

RiteMED Rosuvastatin FC tab 20 mg

rosuvastatin calcium

Packing/Price

30's (P33.75/film-coated tab, P1,012.50/box)

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AA07 - rosuvastatin : Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.

Distributed by Oxford Distributions

Ibandren

Ibandren FC tab 150 mg

ibandronic acid

Packing/Price

1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BA06 - ibandronic acid : Belongs to the class of bisphosphonates. Used in the treatment of bone diseases.

Distributed by RiteMED

RiteMED Rosuvastatin

RiteMED Rosuvastatin FC tab 10 mg

rosuvastatin calcium

Packing/Price

30's (P832.50/box, P27.75/film-coated tab)

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AA07 - rosuvastatin : Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.

RiteMED Rosuvastatin FC tab 20 mg

rosuvastatin calcium

Packing/Price

30's (P33.75/film-coated tab, P1,012.50/box)

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AA07 - rosuvastatin : Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.

Marketed by Bandwell Pharma

Ibandren

Ibandren FC tab 150 mg

ibandronic acid

Packing/Price

1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BA06 - ibandronic acid : Belongs to the class of bisphosphonates. Used in the treatment of bone diseases.